Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Invertebrate gamma-aminobutyric acid (GABA) type A receptors are pentameric ligand-gated ion channels that play a fundamental role in mediating fast inhibitory neurotransmission within the nervous systems of insects, arachnids, and nematodes [1]. These receptors are primarily composed of subunits such as RDL (Resistance to dieldrin), which form a chloride-selective pore that opens upon the binding of GABA, resulting in post-synaptic hyperpolarization and the suppression of neuronal firing [2]. They are of immense significance in agriculture and veterinary medicine as the primary targets for several major classes of insecticides and ectoparasiticides, including phenylpyrazoles like fipronil and isoxazolines like fluralaner [3]. These therapeutic agents typically function as non-competitive antagonists that bind within the ion channel pore, effectively blocking chloride conductance and causing lethal hyperexcitation of the parasite's nervous system [4]. While they share structural similarities with mammalian GABA_A receptors, evolutionary divergence has resulted in distinct pharmacological profiles that allow for high selectivity and safety in host species [5]. However, the emergence of target-site mutations, such as those in the RDL gene, poses a continuous challenge for pest management and necessitates the ongoing development of novel modulators [6].
Non-competitive antagonism of the chloride channel pore or allosteric modulation of the receptor complex, leading to the blockage of inhibitory signals.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Invertebrate gamma-aminobutyric acid type A receptor (GABA_A receptor).